Lobe Sciences Ltd. (LOBE.CN)
CAD 0.03
(0.0%)
CAD 0.03
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 4.13 Million CAD | 0.22% |
| 2022 | 4.12 Million CAD | -34.72% |
| 2021 | 6.31 Million CAD | 91.7% |
| 2020 | 3.29 Million CAD | -9.48% |
| 2019 | 3.63 Million CAD | 2352.81% |
| 2018 | 148.39 Thousand CAD | 185.71% |
| 2017 | 51.93 Thousand CAD | 13.45% |
| 2016 | 45.78 Thousand CAD | -26.2% |
| 2015 | 62.03 Thousand CAD | -42.82% |
| 2014 | 108.49 Thousand CAD | -20.87% |
| 2013 | 137.11 Thousand CAD | 45.12% |
| 2012 | 94.48 Thousand CAD | 3.83% |
| 2011 | 91 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 657.55 Thousand CAD | -23.49% |
| 2024 Q3 | 562.11 Thousand CAD | 0.99% |
| 2024 Q2 | 556.6 Thousand CAD | -15.35% |
| 2023 FY | 4.13 Million CAD | 0.22% |
| 2023 Q1 | 1.94 Million CAD | 67.74% |
| 2023 Q3 | 341.25 Thousand CAD | -65.33% |
| 2023 Q4 | 859.43 Thousand CAD | 151.84% |
| 2023 Q2 | 984.19 Thousand CAD | -49.5% |
| 2022 Q3 | 788.1 Thousand CAD | -23.53% |
| 2022 FY | 4.12 Million CAD | -34.72% |
| 2022 Q4 | 1.16 Million CAD | 47.43% |
| 2022 Q1 | 1.14 Million CAD | -12.75% |
| 2022 Q2 | 1.03 Million CAD | -9.8% |
| 2021 FY | 6.31 Million CAD | 91.7% |
| 2021 Q2 | 2.5 Million CAD | 75.09% |
| 2021 Q3 | 1.21 Million CAD | -51.53% |
| 2021 Q1 | 1.43 Million CAD | 87.19% |
| 2021 Q4 | 1.3 Million CAD | 7.88% |
| 2020 Q3 | 395.25 Thousand CAD | -69.26% |
| 2020 Q1 | 849.78 Thousand CAD | -21.36% |
| 2020 FY | 3.29 Million CAD | -9.48% |
| 2020 Q4 | 764.07 Thousand CAD | 93.31% |
| 2020 Q2 | 1.28 Million CAD | 51.31% |
| 2019 Q1 | 111.76 Thousand CAD | 623.91% |
| 2019 Q2 | 51.95 Thousand CAD | -53.52% |
| 2019 Q3 | 836.01 Thousand CAD | 1509.17% |
| 2019 Q4 | 1.08 Million CAD | 29.26% |
| 2019 FY | 3.63 Million CAD | 2352.81% |
| 2018 Q3 | 8491.00 CAD | -33.15% |
| 2018 Q2 | 12.7 Thousand CAD | -34.69% |
| 2018 FY | 148.39 Thousand CAD | 185.71% |
| 2018 Q1 | 19.44 Thousand CAD | 119.2% |
| 2018 Q4 | 15.43 Thousand CAD | 81.83% |
| 2017 Q3 | 14.6 Thousand CAD | 61.95% |
| 2017 Q2 | 9017.00 CAD | -32.29% |
| 2017 Q1 | 13.31 Thousand CAD | -5.96% |
| 2017 Q4 | 8872.00 CAD | -39.25% |
| 2017 FY | 51.93 Thousand CAD | 13.45% |
| 2016 Q2 | 10.74 Thousand CAD | -27.51% |
| 2016 FY | 45.78 Thousand CAD | -26.2% |
| 2016 Q1 | 14.81 Thousand CAD | 2.69% |
| 2016 Q3 | 7561.00 CAD | -29.61% |
| 2016 Q4 | 14.16 Thousand CAD | 87.29% |
| 2015 Q2 | 19.62 Thousand CAD | -20.35% |
| 2015 Q1 | 24.63 Thousand CAD | -18.1% |
| 2015 FY | 62.03 Thousand CAD | -42.82% |
| 2015 Q4 | 14.43 Thousand CAD | 9.59% |
| 2015 Q3 | 13.16 Thousand CAD | -32.89% |
| 2014 Q4 | 30.07 Thousand CAD | 2.26% |
| 2014 Q3 | 29.41 Thousand CAD | 20.67% |
| 2014 Q2 | 24.37 Thousand CAD | -30.61% |
| 2014 Q1 | 35.12 Thousand CAD | 26.97% |
| 2014 FY | 108.49 Thousand CAD | -20.87% |
| 2013 Q2 | 38.42 Thousand CAD | 169.19% |
| 2013 Q4 | 27.66 Thousand CAD | -22.94% |
| 2013 Q1 | 14.27 Thousand CAD | -70.42% |
| 2013 FY | 137.11 Thousand CAD | 45.12% |
| 2013 Q3 | 35.9 Thousand CAD | -6.57% |
| 2012 Q4 | 48.25 Thousand CAD | 98.49% |
| 2012 Q1 | 85.95 Thousand CAD | 1602.71% |
| 2012 Q2 | 7645.00 CAD | -91.11% |
| 2012 Q3 | 24.31 Thousand CAD | 217.99% |
| 2012 FY | 94.48 Thousand CAD | 3.83% |
| 2011 Q4 | 5048.00 CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 FY | 91 Thousand CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Aion Therapeutic Inc. | 163.11 Thousand CAD | -2433.281% |
| Ayurcann Holdings Corp. | 11.71 Million CAD | 64.731% |
| Blueberries Medical Corp. | 84.22 Thousand CAD | -4806.159% |
| The BC Bud Corporation | 1.28 Million CAD | -222.079% |
| BioNxt Solutions Inc. | 6.73 Million CAD | 38.687% |
| CordovaCann Corp. | 3.86 Million CAD | -7.008% |
| Christina Lake Cannabis Corp. | 4.28 Million CAD | 3.524% |
| Captor Capital Corp. | 16.28 Million CAD | 74.622% |
| City View Green Holdings Inc. | 705.7 Thousand CAD | -485.54% |
| 1CM Inc. | 7.3 Million CAD | 43.456% |
| Global Hemp Group Inc. | 551.7 Thousand CAD | -648.985% |
| Greenway Greenhouse Cannabis Corporation | 4.8 Million CAD | 14.049% |
| IM Cannabis Corp. | 22.63 Million CAD | 81.747% |
| Maple Leaf Green World Inc. | 392.21 Thousand CAD | -953.555% |
| Mountain Valley MD Holdings Inc. | 60 Thousand CAD | -6787.02% |
| Nextleaf Solutions Ltd. | 1.76 Million CAD | -133.721% |
| Ovation Science Inc. | 54.1 Thousand CAD | -7538.1% |
| Pharmadrug Inc. | 1.33 Million CAD | -209.526% |
| Captiva Verde Wellness Corp. | 1.3 Million CAD | -216.546% |
| RAMM Pharma Corp. | 7.48 Million CAD | 44.759% |
| RIV Capital Inc. | 21.1 Million CAD | 80.418% |
| Revive Therapeutics Ltd. | 3.28 Million CAD | -25.763% |
| Red White & Bloom Brands Inc. | 37.75 Million CAD | 89.056% |
| SLANG Worldwide Inc. | 24.6 Million CAD | 83.206% |
| 1933 Industries Inc. | 5.12 Million CAD | 19.375% |
| Red Light Holland Corp. | 2.02 Million CAD | -104.518% |
| Top Strike Resources Corp. | 3.63 Million CAD | -13.78% |
| Xebra Brands Ltd. | -308.42 Thousand CAD | 1439.792% |
| Adastra Holdings Ltd. | 9.36 Million CAD | 55.855% |